Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Net Margin (2016 - 2025)

Marimed has reported Net Margin over the past 15 years, most recently at 11.14% for Q4 2025.

  • Quarterly Net Margin rose 1007.0% to 11.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8.92% through Dec 2025, down 120.0% year-over-year, with the annual reading at 9.04% for FY2025, 116.0% down from the prior year.
  • Net Margin was 11.14% for Q4 2025 at Marimed, down from 7.21% in the prior quarter.
  • Over five years, Net Margin peaked at 23.3% in Q2 2021 and troughed at 26.04% in Q4 2023.
  • The 5-year median for Net Margin is 2.88% (2023), against an average of 2.07%.
  • The largest YoY upside for Net Margin was 4880bps in 2021 against a maximum downside of -5146bps in 2021.
  • A 5-year view of Net Margin shows it stood at 20.61% in 2021, then surged by 164bps to 13.25% in 2022, then tumbled by -296bps to 26.04% in 2023, then rose by 19bps to 21.22% in 2024, then skyrocketed by 47bps to 11.14% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Net Margin are 11.14% (Q4 2025), 7.21% (Q3 2025), and 3.21% (Q2 2025).